Mindbending Drugs: Psychedelics, Cannabis, and Physician Leadership

Abstract

In a recent SXSW presentation, Jeffrey A. Lieberman, MD, explored the potential of psychedelics and cannabis within the realm of physician leadership. Highlighting the high interest in the medicinal use of these substances, Lieberman underscored the necessity of responsible use and rigorous scientific research. In this podcast interview with Mike Sacopulos, he delved into the potential benefits and risks of using mindbending drugs in clinical settings. Lieberman stressed that while these substances may offer therapeutic potential, they must be administered with caution and under the supervision of trained medical professionals. As psychiatry advances, it is crucial for physicians to adopt a balanced, informed perspective and thoroughly comprehend the effects of these substances on the human brain and behavior.